
Relmada Therapeutics, Inc.
RLMDNasdaqCIK 1553643HealthcareFiscal year ends Dec 31
Reports and events: 239 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-09-2817:19 ET | 10-K | Annual reportPeriod 2018-06-30 | 0001213900-18-013238 |
| 2018-08-1716:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-18-011356 |
| 2018-05-1416:32 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001213900-18-006121 |
| 2018-04-0508:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-18-004081 |
| 2018-04-0216:33 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001213900-18-003881 |
| 2018-02-1216:32 ET | 10-Q | Quarterly reportPeriod 2017-12-31 | 0001213900-18-001597 |
| 2018-02-0516:59 ET | 8-K | 5.07 Shareholder vote results | 0001213900-18-001309 |
| 2018-01-1916:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-18-000707 |
| 2017-12-1516:38 ET | DEF 14A | Proxy statementPeriod 2017-12-18 | 0001213900-17-013299 |
| 2017-11-1417:11 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001213900-17-012121 |
| 2017-10-0416:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001213900-17-010300 |
| 2017-09-2816:42 ET | 10-K | Annual reportPeriod 2017-06-30 | 0001213900-17-010097 |
| 2017-06-1516:30 ET | 8-K | 1.01 Entry into a material agreement | 0001213900-17-006520 |
| 2017-06-0816:42 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001213900-17-006258 |
| 2017-05-1808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-17-005449 |
| 2017-05-1514:02 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001213900-17-005185 |
| 2017-04-2716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-17-004315 |
| 2017-02-1716:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-17-001560 |
| 2017-02-1016:17 ET | 10-Q | Quarterly reportPeriod 2016-12-31 | 0001213900-17-001191 |
| 2017-02-0117:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-17-000853 |
| 2016-12-3016:17 ET | DEF 14A | Proxy statementPeriod 2016-01-27 | 0001213900-16-019804 |
| 2016-11-1016:46 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001213900-16-018211 |
| 2016-09-1207:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-16-016676 |
| 2016-09-0917:13 ET | 10-K | Annual reportPeriod 2016-06-30 | 0001213900-16-016664 |
| 2016-06-1716:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-16-014330 |
| 2016-06-0208:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-16-106396 |
| 2016-05-1316:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-16-013287 |
| 2016-05-0917:13 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001213900-16-013088 |
| 2016-02-0516:47 ET | 10-Q | Quarterly reportPeriod 2015-12-31 | 0001213900-16-010641 |
| 2016-01-1308:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-16-010071 |
| 2015-12-3116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-15-009862 |
| 2015-12-3012:42 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009790 |
| 2015-12-2917:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-073168 |
| 2015-12-2308:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009675 |
| 2015-12-2117:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-071997 |
| 2015-12-1408:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009450 |
| 2015-12-1109:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009423 |
| 2015-12-1008:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009388 |
| 2015-12-0917:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-070173 |
| 2015-12-0916:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009378 |
| 2015-12-0910:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-009368 |
| 2015-12-0815:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-069845 |
| 2015-12-0721:56 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-069493 |
| 2015-11-2716:03 ET | DEF 14A | Proxy statementPeriod 2015-12-30 | 0001213900-15-009137 |
| 2015-11-2516:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-15-009111 |
| 2015-11-1216:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-008498 |
| 2015-11-0616:50 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001213900-15-008265 |
| 2015-11-0517:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-15-063147 |
| 2015-11-0508:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-15-008191 |
| 2015-10-2217:43 ET | SC 13D | Ownership report, active investor | 0001144204-15-060273 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.